M D Minden
About
In The Last Decade
M D Minden
19 papers receiving 498 citations
Peers
Comparison fields: 5 of 77
- Hematology 260
- Molecular Biology 256
- Immunology 131
- Oncology 83
- Public Health, Environmental and Occupational Health 74
Countries citing papers authored by M D Minden
This map shows the geographic impact of M D Minden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M D Minden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M D Minden more than expected).
Fields of papers citing papers by M D Minden
This network shows the impact of papers produced by M D Minden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M D Minden. The network helps show where M D Minden may publish in the future.
Co-authorship network of co-authors of M D Minden
This figure shows the co-authorship network connecting the top 25 collaborators of M D Minden. A scholar is included among the top collaborators of M D Minden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M D Minden. M D Minden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | On Subcomplete Forcing | 2 |
| 2 | Three decades of allogeneic bone marrow transplants at the Princess Margaret Hospital. | 2 |
| 3 | Response of the blast stem cells of acute myeloblastic leukemia to G-CSF, GM-CSF, or the ligand for C-KIT, alone or in combination. | 4 |
| 4 | Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy. | 32 |
| 5 | Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed in chronic myelogenous leukaemia and located on 9q33-34.1. | 33 |
| 6 | Differential expression of a basic helix-loop-helix phosphoprotein gene, G0S8, in acute leukemia and localization to human chromosome 1q31. | 36 |
| 7 | Minimal residual disease in bone marrow transplant recipients with chronic myeloid leukemia. | 9 |
| 8 | Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside. Application to the study of regulated drug sensitivity. | 3 |
| 9 | Interactions between retinoic acid and colony-stimulating factors affecting the blast cells of acute myeloblastic leukemia. | 16 |
| 10 | Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate. | 34 |
| 11 | The expression of the proto-oncogene C-kit in the blast cells of acute myeloblastic leukemia. | 137 |
| 12 | Expression of a retinoic acid receptor gene in myeloid leukemia cells. | 89 |
| 13 | Restriction fragment length polymorphism analysis of hematopoietic cells following successful treatment of relapsed acute lymphoblastic leukemia following bone marrow transplantation. | 5 |
| 14 | Heterogeneity in acute myeloblastic leukemia. | 19 |
| 15 | Binding of iodinated recombinant human GM-CSF to the blast cells of acute myeloblastic leukemia. | 47 |
| 16 | The isolation of the human delta chain gene and its expression in normal T cells and T cell leukemias. | 8 |
| 17 | 7 | |
| 18 | Acute myeloblastic leukemia considered as a clonal hemopathy. | 33 |
| 19 | Clonal expansion and progression in acute myeloblastic leukemia. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.